Learn
Patient Navigation Program
Expanded Access Programs
Brain Tumor Symptoms
Guide For High Grade Tumors
Guide For Low Grade Tumors
Checklist For Newly Diagnosed
Video Library
Noteworthy Treatments & Tips
Brain Tumor News
Survivor Stories
Fundraising
DC-Vax
Modeyso™(Onc-201) for DIPG/DMG
Optune
Temodar (Temozolomide)
GammaTile
Newsletter
Subscribe
Change Email
Unsubscribe
Archives
Virtual Trial
What is it?
Join
Submit An Update
Map of Participants
Resources
Copayment Assistance Program
Drug Discount Card
Clinical Trial Search
Brain Tumor Centers
Support Groups
Links To Other Resources
Books
Memorials
About Us
Musella Foundation
Research Grants
Recent Additions To Website
Privacy Policy
Ethics And Values
Our Sponsors
Financials
Contact
donations
Sponsored by
Please click on the above banner for more details
Brain Tumor News
Brain Tumor Conferences / Events
Brain Tumor News!
Subscribe to our Free Brain Tumor News Blast E-Mail Newsletter
Brain Tumor News Blast Archives
Submit a press release or abstract
Recent additions to this website!
Brain Tumor News!
Note: The comments under each article title are the
opinion
of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 3130 to 3149 of 7,806
Previous 20
Next 20
05/06/10
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma.
04/29/10
'Landmark' cancer vaccine gets FDA approval (Editor's Note: this is for Prostate Cancer, but I am sending it because it is the first cancer vaccine to get approval. Hopefully making it easier to get brain tumor vaccines approved!]
04/28/10
The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour.
04/28/10
Patient Trial of Personalized Two-Drug Therapy for Brain Tumors Launched
04/26/10
Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
04/26/10
Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R)
04/26/10
Comment: "5th Annual BTO Lacrosse Classic" to Support Local Pediatric Brain Tumor Foundation
04/23/10
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.
04/23/10
Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent.
04/21/10
Update in Neuro-Oncology Conference
04/16/10
Targeted Agent Blocked Growth of Deadly Brain Cancer in Preclinical Studies
04/15/10
IBTA April 2010 E-News
04/07/10
Cancer vaccines may be on the verge of wider use
04/07/10
Philadelphia Phillies Host Tug McGraw Foundation to Raise Awareness for Brain Tumors
04/01/10
Teva UK Limited Launches Temozolomide Capsules
03/29/10
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study.
03/28/10
Long-term outcomes of childhood cancer survivors in Sweden: a population-based study of education, employment, and income.
03/26/10
Facebook Brain Tumor Fundraiser
03/26/10
AVASTIN now approved (In Canada) to treat colorectal, breast, lung and brain cancer
03/25/10
UPCI Vaccine Trial Offers Options for Patients With Slow-Growing Brain Tumors
Displaying Stories 3130 to 3149 of 7806
Previous 20
Next 20
Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!